Skip to main content

Table 2 Intraoperative data including onset time and duration of action for cisatracurium 0.15 mg/kg in young and elderly patients

From: Comparison of onset time, duration of action, and intubating conditions after cisatracurium 0.15 mg/kg in young and elderly patients

 

Young

Elderly

Difference with 95%CI

P-value

n

31

29

  

Onset time, seconds

Time to TOF 0

199 (59)

297 (120)

98 (49 to 147)

< 0.001

Duration of action, minutes

Time to TOF 0.9

77 (14)

n = 24

89 (17)

n = 26

12 (2.5 to 20.5)

0.01

Time used for intubation, secondsa

92 (74)

115 (157)

23 (−86 to 40)

0.46

Duration of anesthesia, minutes

188 (137)

189 (67)

Duration of surgery, minutes

118 (123)

108 (57)

Administration of supplemental cisatracurium after intubation

2 (6%)

1 (3%)

  

Administration of neostigmine

5 (17%)

1 (3%)

  

Administration of ephedrine or phenylephrine before TOF 0

0

12 (43%)

  

Type of surgery

  

 Plastic/breast

24

19

  

 Orthopedic

7

10

  

Use of inhalational anesthesia during surgery

1 (3%)

0

  1. Data presented as count and frequencies (%) or mean and standard deviation (SD)
  2. In seven patients the duration of action was not determined due to administration of neostigmine, administration of supplemental doses of cistracurium or monitoring difficulties
  3. aFrom taking the laryngoscope until tracheal intubation verified by capnography